Key result
GPT-4 matches traditional ACC/AHA models for 10-year CV risk prediction.
Why the study?
While traditional risk prediction scores are widely used for CVD, artificial intelligence models like GPT-4 offer new opportunities for risk prediction.
Does GPT-4 provide comparable 10-year cardiovascular risk prediction to traditional models in diverse populations?
Observational (n=53,186)
Yes
Does GPT-4 provide comparable 10-year cardiovascular risk prediction to traditional models in diverse populations?
GPT-4 demonstrates comparable performance to established ACC/AHA and Framingham risk scores for 10-year cardiovascular risk prediction across diverse cohorts, even with missing variables.
Cardiovascular disease (CVD) remains a pressing global health concern. While traditional risk prediction methods such as the Framingham and American College of Cardiology/American Heart Association (ACC/AHA) risk scores have been widely used in the practice, artificial intelligence (AI), especially GPT-4, offers new opportunities. Utilizing large scale of multi-center data from 47,468 UK Biobank participants and 5,718 KoGES participants, this study quantitatively evaluated the predictive capabilities of GPT-4 in comparison with traditional models. Our results suggest that the GPT-based score showed commendably comparable performance in CVD prediction when compared to traditional models (AUROC on UKB: 0.725 for GPT-4, 0.733 for ACC/AHA, 0.728 for Framingham; KoGES: 0.664 for GPT-4, 0.674 for ACC/AHA, 0.675 for Framingham). Even with omission of certain variables, GPT-4's performance was robust, demonstrating its adaptability to data-scarce situations. In conclusion, this study emphasizes the promising role of GPT-4 in predicting CVD risks across varied ethnic datasets, pointing toward its expansive future applications in the medical practice.
No takes yet. Share an insight, caveat, or question.
Han et al. (2024) conducted an observational in Cardiovascular disease (n=53,186). GPT-4 vs. ACC/AHA and Framingham risk scores was evaluated on 10-year cardiovascular risk prediction (AUROC) (AUROC 0.725 (UKB), 0.664 (KoGES)). GPT-4 showed comparable performance to traditional models for 10-year cardiovascular risk prediction, achieving an AUROC of 0.725 vs 0.733 (ACC/AHA) in UK Biobank and 0.664 vs 0.674 in KoGES.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: